Follow
Andrew Udy
Andrew Udy
Professor of Research (Critical Care), Monash University
Verified email at monash.edu - Homepage
Title
Cited by
Cited by
Year
Remdesivir for the treatment of Covid-19—preliminary report
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1836, 2020
26082020
Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit
EP Raith, AA Udy, M Bailey, S McGloughlin, C MacIsaac, R Bellomo, ...
Jama 317 (3), 290-300, 2017
10842017
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
MH Abdul-Aziz, JWC Alffenaar, M Bassetti, H Bracht, G Dimopoulos, ...
Intensive care medicine 46, 1127-1153, 2020
5892020
Subtherapeutic initial β-lactam concentrations in select critically ill patients
AA Udy, JM Varghese, M Altukroni, S Briscoe, BC McWhinney, ...
Chest 142 (1), 30-39, 2012
4642012
Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS …
T Fujii, N Luethi, PJ Young, DR Frei, GM Eastwood, CJ French, AM Deane, ...
Jama 323 (5), 423-431, 2020
4502020
Augmented renal clearance: implications for antibacterial dosing in the critically ill
AA Udy, JA Roberts, RJ Boots, DL Paterson, J Lipman
Clinical pharmacokinetics 49, 1-16, 2010
4112010
Sensitivity to fungal allergens is a risk factor for life‐threatening asthma
PN Black, AA Udy, SM Brodie
Allergy 55 (5), 501-504, 2000
4112000
Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations
AA Udy, JP Baptista, NL Lim, GM Joynt, P Jarrett, L Wockner, RJ Boots, ...
Critical care medicine 42 (3), 520-527, 2014
2892014
Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens
JA Roberts, FS Taccone, AA Udy, JL Vincent, F Jacobs, J Lipman
Antimicrobial agents and chemotherapy 55 (6), 2704-2709, 2011
2612011
Clinical implications of antibiotic pharmacokinetic principles in the critically ill
AA Udy, JA Roberts, J Lipman
Intensive care medicine 39, 2070-2082, 2013
2522013
Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcomes and Resource Evaluation (CORE). Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA …
EP Raith, AA Udy, M Bailey, S McGloughlin, C MacIsaac, R Bellomo, ...
Jama 317 (3), 290-300, 2017
2282017
A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance
JP Baptista, AA Udy, E Sousa, J Pimentel, L Wang, JA Roberts, J Lipman
Critical care 15, 1-8, 2011
2242011
Implications of augmented renal clearance in critically ill patients
AA Udy, JA Roberts, J Lipman
Nature Reviews Nephrology 7 (9), 539-543, 2011
2192011
Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients
AA Udy, JA Roberts, AF Shorr, RJ Boots, J Lipman
Critical Care 17, 1-9, 2013
1942013
Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial
H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ...
Jama 326 (17), 1690-1702, 2021
1902021
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients
JJ De Waele, J Lipman, M Akova, M Bassetti, G Dimopoulos, M Kaukonen, ...
Intensive care medicine 40, 1340-1351, 2014
1872014
Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method
P Nasa, E Azoulay, AK Khanna, R Jain, S Gupta, Y Javeri, D Juneja, ...
Critical Care 25, 1-17, 2021
1592021
The impact of disability in survivors of critical illness
CL Hodgson, AA Udy, M Bailey, J Barrett, R Bellomo, T Bucknall, ...
Intensive care medicine 43, 992-1001, 2017
1532017
Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?
AA Udy, J Lipman, P Jarrett, K Klein, SC Wallis, K Patel, CMJ Kirkpatrick, ...
Critical Care 19, 1-9, 2015
1422015
Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization
FB Sime, AA Udy, JA Roberts
Current opinion in pharmacology 24, 1-6, 2015
1392015
The system can't perform the operation now. Try again later.
Articles 1–20